talkmed group
TalkMed shareholders approve Tamarind Health’s privatisation offer
Payment of the scheme consideration is expected to be by Aug 29
65 Equity Partners’ two Singapore funds focus on driving growth in companies regardless of former listing status
The fund manager aims to find businesses that are listed offshore which are underappreciated and have an Asian angle, says its CEO
Fund manager 65 Equity Partners’ role in TalkMed privatisation offer is at odds with its core
With one of its funds’ mandate to support companies eyeing an SGX listing, encouraging the medical group’s delisting through the other is a bad look
TalkMed receives S$0.456 per share in privatisation offer via scheme of arrangement
The company says it provides shareholders with an opportunity to ‘realise their investment in the shares at a premium’
TalkMed H2 net profit dips 2.8% to S$17.9 million despite revenue increase
TERTIARY healthcare services provider TalkMed Group on Tuesday (Feb 20) posted a 2.8 per cent drop in earnings to S$17.9 million for the second half ended Dec 31, 2023, from S$18.4 million in the corr...
TalkMed Group posts 17.7% rise in H1 net profit on improved patient numbers
HEALTHCARE services provider TalkMed Group posted a 17.7 per cent rise in net profit to S$14.3 million for the six months ended Jun 30, 2023, up from S$12.1 million in the corresponding period a year ...
TalkMed Group posts 29% rise in H2 net profit to S$18.4 million on more patient visits
HEALTHCARE services provider TalkMed Group’s net profit for the second half (H2) rose 28.7 per cent, thanks to higher revenue from more oncology patient visits in Singapore.
TalkMed Group H1 net profit rises 12.2% on higher revenue
HEALTHCARE services provider TalkMed Group reported a 12.2 per cent increase in net profit for its first half ended Jun 30, 2022 on the back of higher revenue.
